Type 3 confined placental mosaicisms excluding trisomies 16 are also associated with adverse pregnancy outcomes
- PMID: 31570802
- DOI: 10.1038/s41436-019-0664-1
Type 3 confined placental mosaicisms excluding trisomies 16 are also associated with adverse pregnancy outcomes
Comment in
-
Response to Toutain et al.Genet Med. 2020 Feb;22(2):444-445. doi: 10.1038/s41436-019-0665-0. Epub 2019 Oct 1. Genet Med. 2020. PMID: 31570803 No abstract available.
Comment on
-
Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA.Genet Med. 2020 Feb;22(2):309-316. doi: 10.1038/s41436-019-0630-y. Epub 2019 Aug 8. Genet Med. 2020. PMID: 31391534
References
-
- Grati FR, Ferreira J, Benn P et al. Outcomes in pregnancies with a confined placental mosaicism and implications for prenatal screening using cell-free DNA. Genet Med. 2019 Aug 8; https://doi.org/10.1038/s41436-019-0630-y [Epub ahead of print].
-
- Goldberg JD, Wohlferd MM. Incidence and outcome of chromosomal mosaicism found at the time of chorionic villus sampling. Am J Obstet Gynecol. 1997;176:1349–1352. - DOI
-
- Amor DJ, Neo WT, Waters E, et al. Health and developmental outcome of children following prenatal diagnosis of confined placental mosaicism. Prenat Diagn. 2006;26:443–448. - DOI
-
- Baffero GM, Somigliana E, Crovetto F, et al. Confined placental mosaicism at chorionic villus sampling: risk factors and pregnancy outcome. Prenat Diagn. 2012;32:1102–1108. - DOI
-
- Kalousek DK, Howard-Peebles PN, Olson SB, et al. Confirmation of CVS mosaicism in term placentae and high frequency of intrauterine growth retardation association with confined placental mosaicism. Prenat Diagn. 1991;11:743–750. - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources